EV Manufacturing & Testing (MIT collaboration)
Forecast New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Points of contact
-
- CBER Acquisition Liaison cberacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring specialized isolation kits, reagents, and materials to support an active collaboration with MIT on extracellular vesicle (EV) manufacturing and testing strategies. Solicitation is estimated to release May 1, 2027, with award expected September 1, 2027.
The estimated award value ranges from $25,000 to $250,000. Inquiries should be directed to the FDA's Center for Biologics Evaluation and Research at cberacquisitions@fda.hhs.gov.
Forecast text
Dedicated funding for specialized isolation kits, reagents, and materials to support our active, ongoing collaboration with MIT. This is essential for developing robust Extracellular Vesicle (EV) manufacturing and testing strategies.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast